drugset / Trial / NCT00109473
Trial of Growth Hormone Therapy in Pediatric Crohn's Disease
Phase 2
Completed
22 enrolled
Children's Hospital Medical Center, Cincinnati
Genentech, Inc. · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to determine whether taking a growth hormone (GH) drug called somatropin causes the intestine of a person with Crohn's Disease (CD) to heal faster when compared to a person with Crohn's Disease that does not receive growth hormone drug.
Timeline
- Start
- 2005-04
- Primary completion
- 2009-07
- Completion
- 2009-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Somatropin | Protein / enzyme biologic | 0.075 mg/kg | Subcutaneous |
| Comparator | Budesonide | Small molecule | — | — |
| Comparator | Prednisone | Other / unclassified | — | — |